Home
Categories
Ingredients
Research & Development
Manufacturing
Packaging
Active Nutrition
Cardiovascular
Digestion
Cognitive
Finance
Regulatory
Company News
Events
Directory
Search
Close search
Home
Company
XPhyto Therapeutics
XPhyto Therapeutics
Activities:
Research & Development
Pharmaceutical
X
LinkedIn
Trending Articles
Activating autophagy: a nutritional strategy with longevity applications
As consumers prioritise their healthspan as opposed to their lifespan, the targeted use of dietary spermidine to stimulate autophagy is emerging as a promising healthy ageing...
The perfect pair: how vitamins K2 and D3 combine to support health and well-being
Hydrogen and oxygen, Yin and Yang, Batman and Robin; the world is full of iconic duos that combine to become more than the sum of their parts. One relatively unknown yet...
Degradation of vitamins, probiotics and other active ingredients caused by exposure to heat, water and sunlight
Vitamins and probiotics (and other active ingredients) can be substantially affected by exposure to heat, water and/or sunlight
dsm-firmenich and Lallemand partner to launch early life synbiotic solutions
The solution will contain a combination of human milk oligosaccharides (HMOs) that will mimic breast milk, boosting the infant immune system and gut microbiome
Grøntvedt omega-11 production capacity expands
The company has expanded its omega-11 manufacturing capabilities by around 50% at its Uthaug site
Upcoming event
Vitafoods Europe
14–16 May 2024 | Exhibition | Palexpo, Geneva
See all
Related Content
Research & Development
XPhyto begins R&D operation for CBD-infused beverages
German subsidiary Bunker is working with the International Beverage Research Center Weihenstephan
Manufacturing
Cannabis extraction and processing lab to enter operation in Canada
XPhyto Therapeutics will operate the site located at the University of Alberta
Ingredients
XPhyto Therapeutics inks distribution deal with cannabis grower
The supplier is an international grower and extractor with ongoing EU GMP certification for high THC flower and outdoor high and low THC cannabis strains
Design & Build
Canadian cannabis firm overhauls EU hydroponics and extraction site
XPhyto Therapeutics has engaged Stephen Schroeder with the design, renovation, and commissioning of plant in Bavaria with licence to extract up to 70 strains
Subscribe now